Ewing’s Sarcoma of the Mandible-A Rare Case Report
Author(s) -
Shahid Hassan,
BH Sripathi Rao,
Gunachandra Rai
Publication year - 2011
Publication title -
j med sci
Language(s) - English
Resource type - Journals
eISSN - 2582-063X
pISSN - 0972-110X
DOI - 10.33883/jms.v14i2.90
Subject(s) - medicine , mandible (arthropod mouthpart) , vimentin , sarcoma , desmin , vincristine , lesion , giant cell , pathology , cd99 , anatomy , surgery , cyclophosphamide , chemotherapy , immunohistochemistry , botany , biology , genus
Journal of Medical Sciences 2011;14(2):68-70 expression for CD99 (MIC2), with characteristic membranous pattern and an IMPRESSION drawn was Conformation of diagnosis of EWINGS SARCOMA. Bone Scan was also advised which revealed Reduced uptake over the body of left mandible without rim of enhanced uptake. No evidence of distal bone involvement. A surgical procedure was performed to resect the malignant tissue with generous surgical margins and to reconstruct the resulting defect. The patient underwent a segmental resection of left side including body of mandible. The bony defect was reconstructed using titanium reconstruction plate (Fig. 4). The postoperative panoramic radiograph revealed a wellaligned reconstruction with intact plating (Fig 5). Adjuant Chemotherapy comprised 20 weeks (3 Cycles) of treatment with a four-drug regimen which were Vincristine [VC],Dactinomycin [AC],Cyclophosphamide [CP] and Doxorubicin [AD] after surgery.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom